DrugPatentWatch Database Preview
Purdue Pharma Company Profile
What is the competitive landscape for PURDUE PHARMA, and what generic alternatives to PURDUE PHARMA drugs are available?
PURDUE PHARMA has nine approved drugs.
There are seventy-five US patents protecting PURDUE PHARMA drugs.
Summary for Purdue Pharma
Drugs and US Patents for Purdue Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-007 | Nov 20, 2014 | RX | Yes | No | 9,060,940 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-006 | Nov 20, 2014 | RX | Yes | No | 8,808,740 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | 9,073,933 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | RX | Yes | No | 9,492,391 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-001 | Nov 20, 2014 | RX | Yes | Yes | 9,669,023 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-004 | Apr 5, 2010 | RX | Yes | No | 9,492,392 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Purdue Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | BUTRANS | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021306-005 | Jun 30, 2014 | RE41408 | ➤ Try a Free Trial |
| Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-004 | Sep 24, 2004 | 6,706,281 | ➤ Try a Free Trial |
| Purdue Pharma Lp | MS CONTIN | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019516-003 | Sep 12, 1989 | 4,366,310 | ➤ Try a Free Trial |
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-007 | Nov 20, 2014 | 6,488,963 | ➤ Try a Free Trial |
| Purdue Pharma Lp | BUTRANS | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021306-005 | Jun 30, 2014 | 6,344,211 | ➤ Try a Free Trial |
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-005 | Nov 20, 2014 | 6,488,963 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for PURDUE PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 100 mg, 200 mg and 300 mg | ➤ Subscribe | 2009-06-18 |
| ➤ Subscribe | Transdermal System | 5 mcg/hr, 10 mcg/hr, and 20 mcg/hr | ➤ Subscribe | 2013-06-06 |
| ➤ Subscribe | Extended-release Tablets | 15 mg | ➤ Subscribe | 2007-02-15 |
| ➤ Subscribe | Sublingual Tablets | 1.75 mg and 3.5 mg | ➤ Subscribe | 2012-04-10 |
| ➤ Subscribe | Transdermal System | 15 mcg/hr | ➤ Subscribe | 2013-12-16 |
| ➤ Subscribe | Extended-release Tablets | 30 mg and 60 mg | ➤ Subscribe | 2007-01-03 |
International Patents for Purdue Pharma Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2661573 | ➤ Try a Free Trial |
| Lithuania | 2478896 | ➤ Try a Free Trial |
| Japan | 5373133 | ➤ Try a Free Trial |
| Israel | 197214 | ➤ Try a Free Trial |
| South Korea | 100960200 | ➤ Try a Free Trial |
| Hong Kong | 1156845 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Purdue Pharma Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 00714 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
| 292 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| 636 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: ZOLPIDEM ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES |
| 2013000082 | Germany | ➤ Try a Free Trial | PRODUCT NAME: KOMBINATION VON OXYCODON ALS KOMPONENTE A UND NALOXON ALS KOMPONENTE B IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: 64537.00.00 64538.00.00 64540.00.00 64541.00.00 73083.00.00 73084.00.00 73085.00.00 73086.00.00 20060530 |
| 2015000006 | Germany | ➤ Try a Free Trial | PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718 |
| C/GB04/012 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
